MedPath

Growth of Infants Fed Hydrolysate Formulas

Not Applicable
Completed
Conditions
Growth and Tolerance
Registration Number
NCT02006992
Lead Sponsor
Abbott Nutrition
Brief Summary

Effects on weight and weight gain will be monitored in healthy term infants fed assigned infant formulas.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
195
Inclusion Criteria
  • Infants in good health.
  • Singleton, term birth with a gestational age of 37 to 42 weeks.
  • Birth weight of 2500 g (5 lb 8 oz) or greater.
  • Between 0 and 9 days of age at enrollment.
  • Not receiving vitamin or mineral supplements.
Exclusion Criteria
  • Maternal, fetal or perinatal medical history with potential for adverse effects on growth or development.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
WeightStudy day 1 to 112 days of age
Secondary Outcome Measures
NameTimeMethod
LengthStudy day 1 to 112 days of age
Head CircumferenceStudy day 1 to 112 days of age
Study Formula IntakeEnrollment to 112 days of age
Incidence of Spit UpEnrollment to 112 days of age
Stool PatternEnrollment to 112 days of age

Trial Locations

Locations (8)

Arkansas Children's Hospital

🇺🇸

Little Rock, Arkansas, United States

Dreyer Medical Center

🇺🇸

Aurora, Illinois, United States

PediaResearch, LLC

🇺🇸

Evansville, Indiana, United States

The University of Iowa Hospitals and Clinics

🇺🇸

Iowa City, Iowa, United States

Kentucky Pediatric Research

🇺🇸

Bardstown, Kentucky, United States

Children's Mercy Hospital

🇺🇸

Kansas City, Missouri, United States

NC Children's & Young Adults' Clinical Research Foundation

🇺🇸

Chapel Hill, North Carolina, United States

GrandView Medical Research

🇺🇸

Sellersville, Pennsylvania, United States

Arkansas Children's Hospital
🇺🇸Little Rock, Arkansas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.